Sleep and Neuromuscular Disease

 

 Buy Article Permissions and Reprints

ABSTRACT

Sleep disorders in patients with neuromuscular disease are common, but underrecognized by health care providers, and sometimes by patients themselves. Their symptoms may be confused with those of the underlying disease. Their recognition is an important part of the management of patients with neuromuscular disorders, improving quality of life, and sometimes increasing survival. Inadequate ventilation underlies many sleep disorders, and sleep-related disorders may presage daytime ventilatory disorders with disease progression. Involvement of the central or peripheral nervous system, or both, may disrupt sleep, with the relative contribution of each depending on the specific disorder. The pertinent anatomy, physiology, and clinical features of sleep disorders in neuromuscular diseases and a basic approach to their assessment is discussed. Specific neuromuscular disorders in which sleep is commonly affected are reviewed and the principles of management of sleep disorders summarized.

REFERENCES

• 1 Desai H, Mador J. Sleep in patients with respiratory muscle weakness.  Sleep Med Clin. 2008;  3 541-550
  CrossrefPubMedGoogle Scholar
• 2 Labanowski M, Schmidt-Nowara W, Guilleminault C. Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population.  Neurology. 1996;  47(5) 1173-1180
  PubMedGoogle Scholar
• 3 Benditt J O. The neuromuscular respiratory system: physiology, pathophysiology, and a respiratory care approach to patients.  Respir Care. 2006;  51(8) 829-837 discussion 837-839
  PubMedGoogle Scholar
• 4 Chokroverty S. Sleep-disordered breathing in neuromuscular disorders: a condition in search of recognition.  Muscle Nerve. 2001;  24(4) 451-455
  CrossrefPubMedGoogle Scholar
• 5 Horner R L. Pathophysiology of obstructive sleep apnea.  J Cardiopulm Rehabil Prev. 2008;  28(5) 289-298
  PubMedGoogle Scholar
• 6 Guilleminault C, Shergill R P. Sleep-disordered breathing in neuromuscular disease.  Curr Treat Options Neurol. 2002;  4(2) 107-112
  CrossrefPubMedGoogle Scholar
• 7 Happe S. Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.  Drugs. 2003;  63(24) 2725-2737
  CrossrefPubMedGoogle Scholar
• 8 Bourke S C, Gibson G J. Sleep and breathing in neuromuscular disease.  Eur Respir J. 2002;  19(6) 1194-1201
  CrossrefPubMedGoogle Scholar
• 9 Oztura I, Guilleminault C. Neuromuscular disorders and sleep.  Curr Neurol Neurosci Rep. 2005;  5(2) 147-152
  CrossrefPubMedGoogle Scholar
• 10 Van Lunteren E, Kaminski H J. Disorders of sleep and breathing during sleep in neuromuscular disease.  Sleep Breath. 1999;  3(1) 23-30
  CrossrefPubMedGoogle Scholar
• 11 Brooks S N. Neuromuscular disorders and sleepiness.  Sleep Med Clin. 2006;  1 119-125
  CrossrefPubMedGoogle Scholar
• 12 Baumann C R, Bassetti C L. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.  Neurology. 2004;  62(12) 2337 , author reply 2337
  PubMedGoogle Scholar
• 13 Cochen V, Arnulf I, Demeret S et al.. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome.  Brain. 2005;  128(Pt 11) 2535-2545
  CrossrefPubMedGoogle Scholar
• 14 Fronczek R, Baumann C R, Lammers G J, Bassetti C L, Overeem S. Hypocretin/orexin disturbances in neurological disorders.  Sleep Med Rev. 2009;  13(1) 9-22
  CrossrefPubMedGoogle Scholar
• 15 Martínez-Rodríguez J E, Lin L, Iranzo A et al.. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.  Sleep. 2003;  26(3) 287-290
  PubMedGoogle Scholar
• 16 Nishino S, Kanbayashi T, Fujiki N et al.. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.  Neurology. 2003;  61(6) 823-825
  PubMedGoogle Scholar
• 17 Culebras A. Sleep-disordered breathing in neuromuscular disease.  Sleep Med Clin. 2008;  3 377-386
  CrossrefPubMedGoogle Scholar
• 18 Piper A. Sleep abnormalities associated with neuromuscular disease: pathophysiology and evaluation.  Semin Respir Crit Care Med. 2002;  23(3) 211-219
  Article in Thieme ConnectPubMedGoogle Scholar
• 19 Piper A. Sleep and quality of life in neuromuscular disease. In: Verster JC Sleep and Quality of Life in Clinical Medicine. Totowa, NJ; Humana Press 2008: 209-220
  PubMedGoogle Scholar
• 20 Yumino D, Kasanuki H. Sleep apnea and the heart: diagnosis and treatment.  Rev Cardiovasc Med. 2008;  9(3) 159-167
  PubMedGoogle Scholar
• 21 Guilleminault C, Brooks S N. Excessive daytime sleepiness: a challenge for the practising neurologist.  Brain. 2001;  124(Pt 8) 1482-1491
  CrossrefPubMedGoogle Scholar
• 22 Maislin G, Pack A I, Kribbs N B et al.. A survey screen for prediction of apnea.  Sleep. 1995;  18(3) 158-166
  PubMedGoogle Scholar
• 23 Mehta S. Neuromuscular disease causing acute respiratory failure.  Respir Care. 2006;  51(9) 1016-1021 discussion 1021-1023
  PubMedGoogle Scholar
• 24 Phillips M F, Smith P E, Carroll N, Edwards R H, Calverley P M. Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy.  Am J Respir Crit Care Med. 1999;  160(1) 198-202
  PubMedGoogle Scholar
• 25 Bourke S C, Shaw P J, Gibson G J. Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS.  Neurology. 2001;  57(11) 2040-2044
  PubMedGoogle Scholar
• 26 Corcia P, Meininger V. Management of amyotrophic lateral sclerosis.  Drugs. 2008;  68(8) 1037-1048
  CrossrefPubMedGoogle Scholar
• 27 Arnulf I, Similowski T, Salachas F et al.. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis.  Am J Respir Crit Care Med. 2000;  161(3 Pt 1) 849-856
  PubMedGoogle Scholar
• 28 Gay P C, Westbrook P R, Daube J R, Litchy W J, Windebank A J, Iverson R. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis.  Mayo Clin Proc. 1991;  66(7) 686-694
  PubMedGoogle Scholar
• 29 Ferguson K A, Strong M J, Ahmad D, George C F. Sleep-disordered breathing in amyotrophic lateral sclerosis.  Chest. 1996;  110(3) 664-669
  CrossrefPubMedGoogle Scholar
• 30 Bourke S C, Tomlinson M, Williams T L, Bullock R E, Shaw P J, Gibson G J. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.  Lancet Neurol. 2006;  5(2) 140-147
  CrossrefPubMedGoogle Scholar
• 31 Peysson S, Vandenberghe N, Philit F et al.. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis.  Eur Neurol. 2008;  59(3-4) 164-171
  CrossrefPubMedGoogle Scholar
• 32 Bourke S C, Bullock R E, Williams T L, Shaw P J, Gibson G J. Noninvasive ventilation in ALS: indications and effect on quality of life.  Neurology. 2003;  61(2) 171-177
  CrossrefPubMedGoogle Scholar
• 33 Van Rooij F G, Jurgen Schelhaas H, Lammers G J, Verbeek M M, Overeem S. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.  Amyotroph Lateral Scler. 2008;  , August 7 (Epub ahead of print)
  PubMedGoogle Scholar
• 34 Gustorff B, Dorner T, Likar R et al.. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.  Acta Anaesthesiol Scand. 2008;  52(1) 132-136
  PubMedGoogle Scholar
• 35 Ziegler D. Painful diabetic neuropathy: treatment and future aspects.  Diabetes Metab Res Rev. 2008;  24(Suppl 1) S52-S57
  CrossrefPubMedGoogle Scholar
• 36 Dziewas R, Waldmann N, Böntert M et al.. Increased prevalence of obstructive sleep apnoea in patients with Charcot-Marie-Tooth disease: a case control study.  J Neurol Neurosurg Psychiatry. 2008;  79(7) 829-831
  CrossrefPubMedGoogle Scholar
• 37 Vernon M K, Brandenburg N A, Alvir J M, Griesing T, Revicki D A. Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients.  J Pain Symptom Manage. 2008;  36(1) 54-68
  CrossrefPubMedGoogle Scholar
• 38 Galer B S, Gianas A, Jensen M P. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life.  Diabetes Res Clin Pract. 2000;  47(2) 123-128
  CrossrefPubMedGoogle Scholar
• 39 Koeppen S, Kraywinkel K, Wessendorf T E et al.. Long-term outcome of Guillain-Barré syndrome.  Neurocrit Care. 2006;  5(3) 235-242
  CrossrefPubMedGoogle Scholar
• 40 Dematteis M, Pépin J L, Jeanmart M, Deschaux C, Labarre-Vila A, Lévy P. Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study.  Lancet. 2001;  357(9252) 267-272
  CrossrefPubMedGoogle Scholar
• 41 Dziewas R, Schilling M, Engel P et al.. Treatment for obstructive sleep apnoea: effect on peripheral nerve function.  J Neurol Neurosurg Psychiatry. 2007;  78(3) 295-297
  PubMedGoogle Scholar
• 42 Mayer P, Dematteis M, Pépin J L et al.. Peripheral neuropathy in sleep apnea. A tissue marker of the severity of nocturnal desaturation.  Am J Respir Crit Care Med. 1999;  159(1) 213-219
  PubMedGoogle Scholar
• 43 Nicolle M W. Myasthenia gravis.  Neurologist. 2002;  8(1) 2-21
  CrossrefPubMedGoogle Scholar
• 44 Greim B, Engel C, Apel A, Zettl U K. Fatigue in neuroimmunological diseases.  J Neurol. 2007;  254(Suppl 2) II102-II106
  CrossrefPubMedGoogle Scholar
• 45 Jaretzki III A, Barohn R J, Ernstoff R M Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America et al. Myasthenia gravis: recommendations for clinical research standards.  Neurology. 2000;  55(1) 16-23
  PubMedGoogle Scholar
• 46 Nicolle M W, Rask S, Koopman W J, George C F, Adams J, Wiebe S. Sleep apnea in patients with myasthenia gravis.  Neurology. 2006;  67(1) 140-142
  CrossrefPubMedGoogle Scholar
• 47 Amino A, Shiozawa Z, Nagasaka T et al.. Sleep apnoea in well-controlled myasthenia gravis and the effect of thymectomy.  J Neurol. 1998;  245(2) 77-80
  CrossrefPubMedGoogle Scholar
• 48 Quera-Salva M A, Guilleminault C, Chevret S et al.. Breathing disorders during sleep in myasthenia gravis.  Ann Neurol. 1992;  31(1) 86-92
  CrossrefPubMedGoogle Scholar
• 49 Stepansky R, Weber G, Zeitlhofer J. Sleep apnea and cognitive dysfunction in myasthenia gravis.  Acta Med Austriaca. 1997;  24(3) 128-131
  PubMedGoogle Scholar
• 50 Papazian O. Rapid eye movement sleep alterations in myasthenia gravis.  Neurology. 1976;  26(4) 311-316
  PubMedGoogle Scholar
• 51 Manni R, Piccolo G, Sartori I et al.. Breathing during sleep in myasthenia gravis.  Ital J Neurol Sci. 1995;  16(9) 589-594
  CrossrefPubMedGoogle Scholar
• 52 van Lunteren E, Moyer M, Kaminski H J. Adverse effects of myasthenia gravis on rat phrenic diaphragm contractile performance.  J Appl Physiol. 2004;  97(3) 895-901
  CrossrefPubMedGoogle Scholar
• 53 Keenan S P, Alexander D, Road J D, Ryan C F, Oger J, Wilcox P G. Ventilatory muscle strength and endurance in myasthenia gravis.  Eur Respir J. 1995;  8(7) 1130-1135
  CrossrefPubMedGoogle Scholar
• 54 Ringqvist I, Ringqvist T. Respiratory mechanics in untreated myasthenia gravis with special reference to the respiratory forces.  Acta Med Scand. 1971;  190(6) 499-508
  PubMedGoogle Scholar
• 55 Mier-Jedrzejowicz A K, Brophy C, Green M. Respiratory muscle function in myasthenia gravis.  Am Rev Respir Dis. 1988;  138(4) 867-873
  PubMedGoogle Scholar
• 56 Keesey J C. Does myasthenia gravis affect the brain?.  J Neurol Sci. 1999;  170(2) 77-89
  CrossrefPubMedGoogle Scholar
• 57 Whiting P J, Cooper J, Lindstrom J M. Antibodies in sera from patients with myasthenia gravis do not bind to nicotinic acetylcholine receptors from human brain.  J Neuroimmunol. 1987;  16(2) 205-213
  CrossrefPubMedGoogle Scholar
• 58 Rubinsztein J S, Rubinsztein D C, Goodburn S, Holland A J. Apathy and hypersomnia are common features of myotonic dystrophy.  J Neurol Neurosurg Psychiatry. 1998;  64(4) 510-515
  CrossrefPubMedGoogle Scholar
• 59 Talbot K, Stradling J, Crosby J, Hilton-Jones D. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.  Neuromuscul Disord. 2003;  13(5) 357-364
  CrossrefPubMedGoogle Scholar
• 60 van der Meché F G, Bogaard J M, van der Sluys J C, Schimsheimer R J, Ververs C C, Busch H F. Daytime sleep in myotonic dystrophy is not caused by sleep apnoea.  J Neurol Neurosurg Psychiatry. 1994;  57(5) 626-628
  CrossrefPubMedGoogle Scholar
• 61 Laberge L, Bégin P, Montplaisir J, Mathieu J. Sleep complaints in patients with myotonic dystrophy.  J Sleep Res. 2004;  13(1) 95-100
  CrossrefPubMedGoogle Scholar
• 62 MacDonald J R, Hill J D, Tarnopolsky M A. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy.  Neurology. 2002;  59(12) 1876-1880
  CrossrefPubMedGoogle Scholar
• 63 Giubilei F, Antonini G, Bastianello S et al.. Excessive daytime sleepiness in myotonic dystrophy.  J Neurol Sci. 1999;  164(1) 60-63
  CrossrefPubMedGoogle Scholar
• 64 Cirignotta F, Mondini S, Zucconi M et al.. Sleep-related breathing impairment in myotonic dystrophy.  J Neurol. 1987;  235(2) 80-85
  CrossrefPubMedGoogle Scholar
• 65 Ciafaloni E, Mignot E, Sansone V et al.. The hypocretin neurotransmission system in myotonic dystrophy type 1.  Neurology. 2008;  70(3) 226-230
  CrossrefPubMedGoogle Scholar
• 66 Kumar R. Approved and investigational uses of modafinil: an evidence-based review.  Drugs. 2008;  68(13) 1803-1839
  CrossrefPubMedGoogle Scholar
• 67 Annane D, Moore D H, Barnes P R, Miller R G. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.  Cochrane Database Syst Rev. 2006;  3 CD003218
  PubMedGoogle Scholar
• 68 Alves R S, Resende M B, Skomro R P, Souza F J, Reed U C. Sleep and neuromuscular disorders in children.  Sleep Med Rev. 2009;  13(2) 133-148
  CrossrefPubMedGoogle Scholar
• 69 Suresh S, Wales P, Dakin C, Harris M A, Cooper D G. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population.  J Paediatr Child Health. 2005;  41(9-10) 500-503
  CrossrefPubMedGoogle Scholar
• 70 Khan Y, Heckmatt J Z. Obstructive apnoeas in Duchenne muscular dystrophy.  Thorax. 1994;  49(2) 157-161
  CrossrefPubMedGoogle Scholar
• 71 Mellies U, Ragette R, Schwake C, Baethmann M, Voit T, Teschler H. Sleep-disordered breathing and respiratory failure in acid maltase deficiency.  Neurology. 2001;  57(7) 1290-1295
  CrossrefPubMedGoogle Scholar
• 72 Tölle T, Freynhagen R, Versavel M, Trostmann U, Young Jr J PJ. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.  Eur J Pain. 2008;  12(2) 203-213
  CrossrefPubMedGoogle Scholar
• 73 Tölle T, Xu X, Sadosky A B. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns.  J Diabetes Complications. 2006;  20(1) 26-33
  CrossrefPubMedGoogle Scholar
• 74 Ozsancak A, D'Ambrosio C, Hill N S. Nocturnal noninvasive ventilation.  Chest. 2008;  133(5) 1275-1286
  CrossrefPubMedGoogle Scholar
• 75 Robert D, Argaud L. Clinical review: long-term noninvasive ventilation.  Crit Care. 2007;  11(2) 210 Available at: http://ccforum.com/content/11/2/210 Accessed December 22, 2008; 
  CrossrefPubMedGoogle Scholar
• 76 Annane D, Orlikowski D, Chevret S, Chevrolet J C, Raphaël J C. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders.  Cochrane Database Syst Rev. 2007;  (4) CD001941
  PubMedGoogle Scholar
• 77 Veasey S C, Guilleminault C, Strohl K P, Sanders M H, Ballard R D, Magalang U J. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine.  Sleep. 2006;  29(8) 1036-1044
  PubMedGoogle Scholar
• 78 Miyamoto T, Miyamoto M, Suga T, Aizawa C, Takekawa H, Hirata K. Methylphenidate hydrochloride for excessive daytime sleepiness in a patient with myotonic dystrophy.  Psychiatry Clin Neurosci. 2002;  56(3) 271-272
  CrossrefPubMedGoogle Scholar
• 79 Damian M S, Gerlach A, Schmidt F, Lehmann E, Reichmann H. Modafinil for excessive daytime sleepiness in myotonic dystrophy.  Neurology. 2001;  56(6) 794-796
  CrossrefPubMedGoogle Scholar

M.W. NicolleM.D. F.R.C.P.C. D. Phil. 

Director, Myasthenia Gravis Clinic and EMG Laboratory, University Hospital

London Health Sciences Centre, 339 Windermere Road, London, Ontario, Canada N6A 5A5

Email: mnicolle@uwo.ca